Skip to main content
. 2019 Dec 10;10(65):6997–7009. doi: 10.18632/oncotarget.27367

Figure 3. Inactivation of Sesn1 in Sesn2-/-;KrasLSL-G12D mice does not affect tumor phenotype.

Figure 3

(A) Western blot analysis of lung lysates from control, Sesn2-/-, Sesn1-/-, and Sesn1F/F animals. (B–D) Sesn1-/-; Sesn2-/-;KrasLSL-G12D and Sesn2-/-;KrasLSL-G12D animals produce tumors of similar morphology (B), number (C), and size (D). 4 mice were analyzed per group. The data in (C) and (D) are presented as mean ± S.D. P values were calculated using a two-tailed student’s t-test; n.s. – not significant. (E) Sesn2-/-;KrasLSL-G12D and Sesn1-/-;Sesn2-/-;KrasLSL-G12D animals have a similar lifespan. 12 mice were analyzed per group.